Nidan Laboratories and Healthcare Limited Financial Ratios
NIDAN · Healthcare · Current price ₹13.55
P/E ratio
12.6x
P/B ratio
0.3x
ROE
2.2%
ROCE
5.4%
Debt / Equity
0.16
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 12.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 2.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 5.4% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.16 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Nidan Laboratories and Healthcare Limited's latest numbers.
Nidan Laboratories and Healthcare Limited profitability
Nidan Laboratories and Healthcare Limited generates a return on equity of 2.2% and a return on capital employed of 5.4%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.16 and a P/E of 12.6x, Nidan Laboratories and Healthcare Limited is conservatively financed. Our overall business-quality score for the company is 3.7 / 10.
Understand the ratios
More on Nidan Laboratories and Healthcare Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.